Endogenous opiate involvement in acute and chronic stress-induced changes in plasma LH concentrations in the male rat.
The present study was carried out to examine the possible role of the endogenous opioid peptides ( EOP 's) on the pituitary luteinizing hormone (LH) response to both acute and chronic stress and to food deprivation. Thirty minutes after acute (2 min.) exposure to ether, plasma LH levels were elevated compared to controls; morphine (MOR) treatment prior to stress prevented this response. More prolonged etherization (15 minutes) significantly depressed circulating LH, whereas naltrexone ( NALT ), a specific opiate antagonist, reversed this decline. Immobilization for 8 hours resulted in a significant initial increase in LH release, followed by a decline toward baseline levels. Naltrexone treatment increased the magnitude of the acute LH rise, and attenuated the subsequent decrease in plasma LH. The effect of chronic stress on circulating LH was also examined. Plasma LH levels were depressed for 3 consecutive days following subcutaneous gauze pad implantation, whereas 3 daily NALT injections returned LH to control levels. Complete food deprivation for 5 days also resulted in a significant decline in circulating LH. Injection of NALT 3 times daily reversed this decline on days 2, 3 and 4 of treatment. These results support the hypothesis of a mediatory role for the EOP 's in the effect of both chronic stress and food deprivation on LH release in the rat.
D000818:Animals; D004723:Endorphins / Q000502:physiology*; D007987:Gonadotropin-Releasing Hormone / Q000378:metabolism; D007986:Luteinizing Hormone / Q000097:blood*; D008297:Male; D009020:Morphine / Q000494:pharmacology; D009271:Naltrexone / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013217:Starvation / Q000097:blood; D013312:Stress, Physiological / Q000097:blood*
D004723:Endorphins; D007987:Gonadotropin-Releasing Hormone; D009271:Naltrexone; D009020:Morphine; D007986:Luteinizing Hormone